Fitzpatrick, Mace cosponsor bill to permit Medicare coverage for PFAS testing

U.S. Reps. Brian Fitzpatrick (R-PA) and Nancy Mace (R-SC) on July 26 proposed legislation that would provide no-cost Medicare coverage to test blood for toxic per- and polyfluoroalkyl substances (PFAS).

The lawmakers signed on as original cosponsors of the bipartisan Expanding Seniors’ Access to PFAS Testing Act, H.R. 4917, which is sponsored by U.S. Rep. Dan Kildee (D-MI). Both Rep. Fitzpatrick and Rep. Kildee are co-chairs of the Bipartisan Congressional PFAS Task Force.

“PFAS chemicals represent a grave public health threat, and we must ensure that individuals in need have access to medical tests to determine exposure to these harmful, forever chemicals,” Rep. Fitzpatrick said. “I am proud to lead [H.R. 4917] to ensure that Medicare beneficiaries and our seniors have access to testing, with my friend Congressman Kildee, who has been a fantastic partner on this important issue.”

“My legislation, supported by Republicans and Democrats, is urgently needed to ensure those exposed to PFAS get the health care they need,” said Rep. Kildee. “As we work to clean up harmful PFAS chemicals across the country, I am committed to ensuring Michigan seniors have access to these tests at no cost to them.”

Rep. Mace called H.R. 4917 a critical step toward protecting the health and well-being of America’s senior citizens.

“By requiring Medicare to cover and pay for PFAS blood testing, we are ensuring our seniors have access to the same preventative services as other important health screenings,” said Rep. Mace. “The harmful effects of PFAS chemicals are well-documented, and it is our duty to prioritize the health of our seniors by providing them with the necessary tools for early detection and intervention. 

“This legislation will empower our seniors to take control of their health and live with peace of mind,” she added.